Literature DB >> 30354832

PARP-1 (Poly[ADP-Ribose] Polymerase-1).

Rhéure Alves-Lopes1, Rhian M Touyz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30354832      PMCID： PMC6218001          DOI： 10.1161/HYPERTENSIONAHA.118.11830

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  18 in total

Review 1.  Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.

Authors:  Nathan A Berger; Valerie C Besson; A Hamid Boulares; Alexander Bürkle; Alberto Chiarugi; Robert S Clark; Nicola J Curtin; Salvatore Cuzzocrea; Ted M Dawson; Valina L Dawson; György Haskó; Lucas Liaudet; Flavio Moroni; Pál Pacher; Peter Radermacher; Andrew L Salzman; Solomon H Snyder; Francisco Garcia Soriano; Robert P Strosznajder; Balázs Sümegi; Raymond A Swanson; Csaba Szabo
Journal:  Br J Pharmacol       Date:  2017-03-26       Impact factor: 8.739

Review 2.  On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1.

Authors:  Xin Luo; W Lee Kraus
Journal:  Genes Dev       Date:  2012-03-01       Impact factor: 11.361

3.  Angiotensin II-mediated endothelial dysfunction: role of poly(ADP-ribose) polymerase activation.

Authors:  Csaba Szabó; Pál Pacher; Zsuzsanna Zsengellér; Anne Vaslin; Katalin Komjáti; Rita Benkö; Min Chen; Jon G Mabley; Márk Kollai
Journal:  Mol Med       Date:  2004 Jan-Jun       Impact factor: 6.354

4.  Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.

Authors:  Karine Oumouna-Benachour; Chetan P Hans; Yasuhiro Suzuki; Amarjit Naura; Rahul Datta; Souad Belmadani; Kenneth Fallon; Cooper Woods; A Hamid Boulares
Journal:  Circulation       Date:  2007-04-16       Impact factor: 29.690

Review 5.  Pharmacotherapy of abdominal aortic aneurysms.

Authors:  Joe Dawson; Edward Choke; Saiqa Sayed; Gillian Cockerill; Ian Loftus; Matt M Thompson
Journal:  Curr Vasc Pharmacol       Date:  2006-04       Impact factor: 2.719

Review 6.  The multifaceted roles of PARP1 in DNA repair and chromatin remodelling.

Authors:  Arnab Ray Chaudhuri; André Nussenzweig
Journal:  Nat Rev Mol Cell Biol       Date:  2017-07-05       Impact factor: 94.444

7.  Restoration of the endothelial function in the aortic rings of apolipoprotein E deficient mice by pharmacological inhibition of the nuclear enzyme poly(ADP-ribose) polymerase.

Authors:  Rita Benkö; Pál Pacher; Anne Vaslin; Márk Kollai; Csaba Szabó
Journal:  Life Sci       Date:  2004-07-23       Impact factor: 5.037

8.  Experimental models of abdominal aortic aneurysms.

Authors:  Janice C Tsui
Journal:  Open Cardiovasc Med J       Date:  2010-11-26

9.  Abdominal aortic aneurysm: Treatment options, image visualizations and follow-up procedures.

Authors:  Zhong-Hua Sun
Journal:  J Geriatr Cardiol       Date:  2012-03       Impact factor: 3.327

Review 10.  PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes.

Authors:  Rebecca Gupte; Ziying Liu; W Lee Kraus
Journal:  Genes Dev       Date:  2017-01-15       Impact factor: 11.361
View more
  2 in total

1.  Contributions of PARP-1 rs1136410 C>T polymorphism to the development of cancer.

Authors:  Hunian Li; Yongjiu Zha; Fang Du; Jie Liu; Xiaoquan Li; Xu Zhao
Journal:  J Cell Mol Med       Date:  2020-10-27       Impact factor: 5.295

2.  Tissue remodelling and increased DNA damage in patients with incompetent valves in chronic venous insufficiency.

Authors:  Miguel A Ortega; Oscar Fraile-Martínez; Cielo García-Montero; Leonel Pekarek; Miguel A Alvarez-Mon; Luis G Guijarro; Maria Del Carmen Boyano; Felipe Sainz; Melchor Álvarez-Mon; Julia Buján; Natalio García-Honduvilla; Ángel Asúnsolo
Journal:  J Cell Mol Med       Date:  2021-06-20       Impact factor: 5.310
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.